One lot of Xanax recalled nationwide over quality issue, FDA says
medicalxpress - A widely used anxiety medication is being pulled from shelves due to "failed dissolution specifications," the U.S. Food and Drug Administration (FDA) said.
AI Summary: Regulators have flagged a quality issue and a manufacturer has recalled a specific lot of Xanax nationwide. Pharmacies and patients have been advised to check lot numbers and return affected pills; health officials emphasize the recall is precautionary, urging anyone with concerns to consult their pharmacist or clinician rather than panic-buy substitutes.
Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61
Related Stories
Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128
FDA Approves Immunotherapy Combo for Bladder Cancer / 6 months
FDA to Remove Black Box Warnings from Menopausal Hormone Therapies / 6 months
FDA commissioner Marty Makary resigns amid mounting scrutiny / 19 days
RFK Jr launches plan to curb antidepressant overprescription / 22 days
FDA Lifts Hold on Intellia’s Phase 3 Gene Editing Trial / 4 months
FDA Abortion Pill Decisions Rooted in Science / 4 months
FDA rejects Corcept’s cortisol modulator triggering setback / 4 months
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Infant Health, Medicaid, Reproductive Health, Product Recall and look for the RSS link.
StackHealth Time Machine